noscript

News and Announcements

Cellmid Limited – R&D; Tax Refund Received

  • Published October 04, 2013 10:56AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

SYDNEY, Friday, 04 October 2013: Cellmid Limited (ASX: CDY) advises that it has received $711,895.35 refund under the Federal Government’s R&D Tax Incentive Scheme.

The tax refund relates to the cost of research and development conducted by the Company on its midkine technology portfolio during the 2013 financial year and was calculated as 45% of eligible expenditure.

A further $42,157 is expected in the coming weeks in relation to qualifying research and development activity in the Company’s subsidiary, Advangen International Pty Ltd.

The funds will be used to advance Cellmid’s product development programmes.

To read the full ASX Release please click on the document below.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now